A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
This study will be used to determine the maximum tolerated dose of oral clofarabine when administered daily for 14 consecutive days repeated every 21 days.
Myelodysplastic Syndromes
DRUG: clofarabine|DRUG: clofarabine
Maximum Tolerated dose levels, First Cycle
PK profile, After MTD is established|Food effect on profile, After MTD is established|Activity of clofarabine in this dosing regimen, Duration of Study
This study will be used to determine the maximum tolerated dose of oral clofarabine when administered daily for 14 consecutive days repeated every 21 days.